Effects of cerebrospinal fluid drainage on patients with aneurysmal subarachnoid hemorrhage: an updated systematic review and meta-analysis Authors: Xinlong Chen, Peijun Zhao, Xingyuan Huang, Wujun He, Yangjingtian Hu, Huanyu Tang, Xiaoping Tang, Long Zhao Published: 2025 ABSTRACT AbstractObjectiveCerebrospinal fluid drainage (CSFD) has been reported to be beneficial in patients with aneurysmal subarachnoid hemorrhage (aSAH), but there are controversial results among different studies. Moreover, the complications associated with CSFD have received widespread attention. In this study, an updated systematic review and meta-analysis were conducted with the aim of evaluating the relationships between CSFD and outcomes in aSAH patients.MethodsA systematic search was carried out for eligible English publications up to 1 July 2025 in the PubMed, Embase, Cochrane Library, and Web of Science databases. The primary outcomes were a good prognosis and death, and the secondary outcomes included hydrocephalus, cerebral vasospasm (CVS), delayed cerebral ischemia (DCI), and intracranial infection (II). Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated by meta-analysis.ResultsA total of 3442 patients from 20 studies were included in the meta-analysis; 2258 patients received CSFD, and 1184 patients did not undergo drainage. Pooled analysis revealed that CSFD improved the prognosis (OR: 1.74; 95% CI: 1.15–2.61; P < 0.01) and reduced mortality (OR: 0.54; 95% CI: 0.38–0.76; P < 0.01). Meta-analysis of secondary outcomes suggested that patients who received CSFD had a lower incidence of CVS (OR: 0.52; 95% CI: 0.37–0.73; P < 0.01) and DCI (OR: 0.57; 95% CI: 0.40–0.81; P < 0.01) than those who did not receive drainage, but CSFD did not reduce the incidence of hydrocephalus. CSFD increased the risk of II (OR: 2.31; 95% CI: 1.24–4.29; P < 0.01). Subgroup analysis revealed that the results of different study methods and different drainage methods all showed that CSFD reduces the incidence of CVS but has no effect on the occurrence of hydrocephalus. However, for primary outcomes and other secondary outcomes, the results were inconsistent across subgroups.ConclusionsThe current data show that CSFD tends to improve prognosis and reduce the incidence of cerebral vasospasm and delayed cerebral ischemia. However, it may increase the risk of II and has no effect on the occurrence of hydrocephalus. More well-designed randomized controlled trials are needed.Supplementary InformationThe online version contains supplementary material available at 10.1007/s00415-025-13578-z.Keywords: Cerebrospinal fluid drainage, Lumbar drainage, External ventricular drain, Aneurysmal subarachnoid hemorrhage, Outcome, Complication Introduction Aneurysmal subarachnoid hemorrhage (aSAH) accounts for 5% of all strokes and is among the most debilitating of all cerebrovascular diseases [1]. With advances in diagnostic technologies and therapeutic strategies, mortality after aSAH has decreased significantly over the past 30 years, but sequelae such as irreversible sensorimotor disorders, cognitive function decline and mental disorders induced by complications after aSAH still cannot be overlooked [2, 3]. It is generally believed that persistent brain damage caused by blood clots and inflammatory products following bleeding is responsible for deterioration in patients [4, 5]. Both pathophysiological and clinical studies have indicated that the timely removal of blood clots is beneficial for aSAH patients, with the possibility of alleviating delayed cerebral ischemia (DCI), preventing hydrocephalus, and improving prognosis [5, 6]. However, conclusions concerning the method of subarachnoid blood clearance and its clinical value and risks are insufficient [7]. Extracorporeal cerebrospinal fluid drainage (CSFD) has been widely utilized the in clinical diagnosis and treatment of neurological diseases [8–10]. In patients with intraventricular hemorrhage and subarachnoid hemorrhage, CSFD accelerates the removal of blood clots and metabolites from the subarachnoid space and ventricles. Most studies have shown that CSFD can reduce complications and improve prognosis, but the results of different drainage methods and research strategies are inconsistent [11–13]. Moreover, the differences in the safety and efficacy of different drainage methods are still unclear. Lumbar drainage (LD) and external ventricular drainage (EVD), as the most common drainage methods, have been widely studied and reported, and both operations have been shown to remove blood clots, improve cerebrospinal fluid circulation and reduce posthemorrhagic complications [14–17]. EVD is applied to treat acute hydrocephalus, subarachnoid hemorrhage, and other diseases by draining blood CSF from the lateral ventricles [18]. However, the risk of infection, brain tissue damage and bleeding associated with drainage tube implantation is a challenge for the clinical application. LD is a simple, cost-effective, and minimally invasive treatment that allows bloody CSF to drain through a drainage tube inserted into the subarachnoid space at the lumbar level [7, 16]. However, intracranial hypotension or brain herniation induced by LD must be carefully considered during treatment [19]. Therefore, we included the latest literature for an updated meta-analysis to comprehensively evaluate the effects of CSFD on the outcomes of SAH, as well as the differences in efficacy and safety between LD and EVD. Methods Search strategy The research question in this study was, “Is CSFD safe and effective for patients with aSAH?” To achieve maximum sensitivity for the search strategy, we used “aneurysm”, “subarachnoid hemorrhage”, “SAH”, “aneurysmal Subarachnoid Hemorrhage”, “aSAH”, “Spontaneous Subarachnoid Hemorrhage”, “cerebrospinal fluid”, “drainage”, “extraventricular drainage”, “external ventricular drain”, “EVD”, “lumbar drainage”, and “LD” as keywords or MeSH terms (Supplementary Table S1). Two researchers independently and systematically searched for relevant studies between CSFD and aSAH in PubMed, Embase, the Cochrane Library, and Web of Science for the period from inception up to 1 July 2025. In addition, a manual search of the reference section of the retrieved articles was conducted to identify additional published literature related to this study. This protocol was registered in PROSPERO and guided by the principles of PRISMA. Inclusion criteria Two researchers independently assessed whether the literature met the criteria by reading the titles and abstracts, and two other fellows rescreened the potential articles by reviewing the full text. In the screening process, if a disagreement occurred, it was resolved through discussion. The literature inclusion criteria were as follows: (1) aSAH diagnosed by computed tomography (CT) or digital subtraction angiography (DSA); (2) patient age > 18 years; (3) lumbar drainage or external ventricular drainage; and 4. detailed information on the primary or secondary outcomes. The exclusion criteria were as follows: (1) no detailed description of the method of drainage or other treatments that affect the effectiveness of drainage; (2) reviews, commentaries, guidelines, or case reports; (3) no controlled studies; (4) animal, cell, or pathophysiological studies; (5) the primary outcome of the original study did not include the prognosis or complications included in this study; (6) modified Jadad score < 3 or Newcastle–Ottawa Scale (NOS) score < 5 for literature quality; and (7) non-English language literature. Two researchers assessed the quality of the studies, and they discussed any differences between their results. The modified Jadad scale was used for the evaluation of randomized controlled studies (RCTs), while the Newcastle–Ottawa Scale (NOS) was used for the assessment of cohort studies and case–control studies. Outcome measures The primary outcomes of this study included a good prognosis and death. A favorable prognosis was defined as a Glasgow Outcome Scale (GOS) score > 3 or modified Rankin Scale (mRS) score < 3. Death was defined as mortality during hospitalization or discharge due to subarachnoid hemorrhage or its complications. Secondary outcomes include shunting-dependent hydrocephalus, cerebral vasospasm (CVS), DCI, bleeding events and intracranial infection (II). Shunting-dependent hydrocephalus was defined as hydrocephalus requiring permanent shunting surgery after subarachnoid hemorrhage or hydrocephalus requiring shunting, clearly reported in the text. CVS was defined as evidence of vasospasm as suggested by transcranial Doppler ultrasound or cerebral angiography, regardless of whether clinical symptoms were associated with cerebral vasospasm. DCI was defined as a decline in consciousness that did not occur immediately after aneurysm clamping or new focal neurological deficits that occurred at least 72 h after bleeding, excluding other causes of neurological deficit, such as hyponatremia, hypoxia, and infection. Intracranial infection was defined as fever with significant signs of intracranial hypertension or meningitis irritation, laboratory tests of the cerebrospinal fluid suggesting a definite possibility of infection, or pathogenic tests of the cerebrospinal fluid revealing pathogens that may cause intracranial infections. Suspected infections without clear evidence were not included in the category of intracranial infections. Bleeding events were defined as the development of a new epidural hematoma, subdural hematoma, intraventricular hemorrhage, or cerebral hemorrhage after aneurysm surgery. Data extraction Data sources included the full text and supplementary material. Two researchers working independently extracted and entered data into an Excel spreadsheet. A third researcher checked the extracted data to ensure accuracy. When inconsistent information was found, it was resolved through discussion. The collected data were as follows: first author, publication year, study design, country, sample size, modified Fisher grade, drainage methods, functional prognosis, death, hydrocephalus, CVS, DCI, intracranial infection and bleeding events. Some of the other outcomes had very little extractable data, and analyzing the data for these outcomes was less meaningful. Patients who received LD or EVD during treatment were assigned to the experimental group, and those who did not receive drainage operations were assigned to the control group. Low-grade was defined as modified Fisher grade ≤ 2, while high-grade was defined as modified Fisher grades 3 and 4. Statistical analysis Data concerning prognosis and complications were used to calculate the individual odds ratio (OR) and 95% confidence interval (CI) for each study. The Cochran Q test and I2 statistic were used to calculate heterogeneity between studies; P < 0.1 indicated significant heterogeneity, and I2 > 50% indicated high heterogeneity. A random-effects model was used in cases of significant heterogeneity; otherwise, a fixed-effects model was used. A meta-regression analysis was performed to evaluate the associations between outcomes and study type, drainage method, publication year, region, and population, with P < 0.05 considered to indicate a possible source of heterogeneity. Outcomes with low heterogeneity or relatively few studies (n < 10) were not subjected to further meta-regression. Subgroup analyses were conducted for study type and drainage method to determine whether the results were consistent across studies of different study types or different drainage methods. Funnel plots and Egger's test were used to detect publication bias. Trim-and-fill analysis was used when there was a large publication bias. Sensitivity analyses were conducted using the leave-one-out method, and results that did not change after the sensitivity analysis were considered robust. All statistical tests were conducted using Stata 14.0 software (College Station, Texas). Results Literature search and study characteristics The flow diagram shows the entire literature screening process and the inclusion criteria (Fig. 1). A total of 3833 records were discovered by searching the PubMed, Embase, Cochrane Library, and Web of Science databases. A total of 1746 duplicates were excluded, and 2050 studies were excluded after the titles and abstracts were read. After the full-text screening, 17 records were excluded: 3 not related to aSAH, 4 without a control group, 9 with special drainage, and 1 without full-text availability. Finally, 20 studies with a total of 3442 patients were included in this meta-analysis [8–17, 19–28]. Among these studies, 5 were RCTs, 15 were cohort studies, 10 studies used LD, 6 studies used EVD, and 4 studies compared LD with EVD (Table 1). 15 studies reported a favorable prognosis in 2935 patients, 9 studies reported mortality in 1982 patients, 16 studies reported hydrocephalus in 3083 patients, 15 studies reported CVS in 2646 patients, 6 studies reported DCI in 842 patients, 5 studies recorded bleeding events in 1001 patients and 9 studies reported intracranial infection in 1845 patients. Moreover, all the studies were evaluated based on methodological principles (Supplementary Tables S2 and S3). Flowchart of the study selection process Table 1Main characteristics of included studiesStudy IDStudy designCountrySample sizemFGGrouping methodsFavorable prognosis(EG vs CG)Mortality(EG vs CG)Hydrocephalus(EG vs CG)CVS(EG vs CG)DCI(EG vs CG)II(EG vs CG)BE(EG vs CG)EGCGYamamoto. I. 1989RSCJapan205–EVDNo-drainage(98/136 vs 50/69)(14/136 vs 11/69)(31/136 vs 9/69)(54/136 vs 28/69)–––Klimo, P. 2004RSCUSA1673–4LDEVD(64/81 vs 39/86)–(19/81 vs 28/86)(14/81 vs 44/86)–––Otawara, Y. 2007RSCJapan78–EVDNo-drainage(38/38 vs 40/40)–(2/38 vs 0/40)(3/38 vs 5/40)–(1/38 vs 0/40)–Kwon, O. Y 2008RSCKorea1072–4LDNo-drainage(45/47 vs 36/60)(1/47 vs 9/60)(8/47 vs 5/60)(11/47 vs 38/60)–––Al-Tamimi 2012RCTUK2102–4LDNo-drainage(81/105 vs 83/105)(4/105 vs 5/105)(6/105 vs 8/105)–(22/105 vs 37/105)(2/105 vs 0/105)–Maeda, Y. 2012RSCJapan51–LDEVD(22/34 vs 4/17)–(6/34 vs 7/17)(7/34 vs 2/17)––Della, P, G. 2014RSCItaly1412–4EVDNo-drainage––-(7/80 vs 14/61)(3/80 vs 5/61)––Sun, C. 2014RCTChina148–LDEVD––(15/72 vs 11/76)(13/72 vs 14/76)–––He, J. Q. 2015RCTChina60–EVDNo-drainage(15/30 vs 6/30)––(6/30 vs 14/30)–(6/30 vs 5/30)Park, S. 2015RSCKorea2342–4LDNo-drainage(103/126 vs 76/108)(6/126 vs 11/108)(26/126 vs 28/108)(24/126 vs 45/108)–(5/126 vs 0/108)Borkar, S. A. 2018RCTIndia60–LDNo-drainage–(2/30 vs 2/30)(3/30 vs 2/30)(9/30 vs 19/30)–(5/30 vs 2/30)Jeong, J. H 2020RSCKorea1073LDNo-drainage(25/28 vs 68/79)(0/28 vs 1/79)(2/28 vs 4/79)–(5/28 vs 22/79)––Fang, Y. 2020RSCChina1930–4LDNo-drainage(105/113 vs 63/80)–(6/113 vs 22/80)(48/113 vs 36/80)(35/113 vs 27/80)(1/113 vs 2/80)Ohbuchi, H 2021RSCJapan102–EVDNo-drainage–––(10/49 vs 17/53)(3/49 vs 5/53)(2/49 vs 0/53)Nelson, S. E. 2022RSCUSA56–EVDNo-drainage–––––(3/31 vs 0/25)–Chen, Y.-H 2023RSCChina893–4LDNo-drainage(41/48 vs 23/41)–(21/48 vs 22/41)–(11/48 vs 15/41)–(27/48 vs 21/41)Kim, D. Y. 2023RSCKorea4383–4LDNo-drainage(132/229 vs 105/209)(17/229 vs 30/209)(25/229 vs 60/209)(23/229 vs 35/209)–(1/229 vs 3/209)(7/219 vs 12/209)Wolf, S. 2023RCTGermany2871–4LDNo-drainage(97/144 vs 79/143)(19/144 vs 25/143)(41/144 vs 42/143)(41/144 vs 48/143)–––Terakado. T 2024RSCJapan3751–4LDNo-drainage(176/324 vs 35/51)-(78/324 vs 6/51)(42/324 vs 6/51)–(48/324 vs 3/51)(13/138 vs 2/51)An X. 2025RSCChina3341–4LDEVD(105/167 vs 84/167)(8/167 vs 13/167)(5/167 vs 5/167)––(27/167 vs 30/167)–mFG, modified Fisher grade; EG, experimental group; CG, control group; CVS, cerebral vasospasm; DCI, delayed cerebral ischemia; II, intracranial infection; BE, bleeding events; RSC, retrospective cohort; RCT, randomized controlled trials; EVD, external ventricular drainage; LD, lumbar drainage Main characteristics of included studies mFG, modified Fisher grade; EG, experimental group; CG, control group; CVS, cerebral vasospasm; DCI, delayed cerebral ischemia; II, intracranial infection; BE, bleeding events; RSC, retrospective cohort; RCT, randomized controlled trials; EVD, external ventricular drainage; LD, lumbar drainage Primary outcomes Twelve studies reported a favorable prognosis after discharge (1368 patients with CSFD and 1015 patients without CSFD). According to the pooled effect size, patients who received CSFD had a significantly more favorable prognosis than those who did not receive drainage (OR: 1.74, 95% CI: 1.15–2.61, P < 0.01) (Fig. 2A). A random-effects model was used because of high heterogeneity (P = 0.000, I2 = 71.5%), and a meta-regression was performed. Study type, drainage method, and population were not sources of heterogeneity in the meta-regression (Supplementary Table S4A). We conducted subgroup analyses based on study type, and only the cohort study subgroup (OR: 1.84, 95% CI: 1.06–3.17, P = 0.03) showed that drainage had a positive effect on prognosis (Fig. 2B). In the subgroup analysis by drainage method, the LD group (OR: 1.75, 95% CI: 1.11–2.78, P = 0.01) showed a significantly improvement in patient prognosis (Fig. 2C). Forest plots of CSFD for favorable prognosis. A Forest plot of CSFD improving favorable prognosis. B Forest plot of the subgroup analyses for CSFD improving favorable prognosis by study type. C Forest plot of the subgroup analyses for CSFD improving favorable prognosis by drainage methods For mortality, a total of 1588 patients were examined in 8 studies, 845 in the experimental group and 743 in the control group. The results of the meta-analysis revealed that drainage reduced mortality (OR: 0.54, 95% CI: 0.38–0.76, P < 0.01) (Fig. 3A). The results of the meta-analysis did not suggest heterogeneity (P = 0.784, I2 = 0.0%), and no further meta-regression was performed. The results of the subgroup analysis by study type; were different; in the cohort study subgroup, that drainage reduced patient mortality (OR: 0.45, 95% CI: 0.29–0.69, P < 0.01), whereas in the RCT subgroup, drainage did not reduce patient mortality (OR: 0.75, 95% CI: 0.43–1.31, P = 0.31) (Fig. 3B). According to the subgroup analysis by drainage method, LD reduced patient mortality (OR: 0.53, 95% CI: 0.37–0.77, P < 0.01), whereas EVD did not reduce patient mortality (OR: 0.61, 95% CI: 0.26–1.41, P = 0.25) (Fig. 3C). Forest plots of CSFD for mortality. A Forest plot of CSFD reducing mortality. B Forest plot of the subgroup analyses for CSFD reducing mortality by study type. C Forest plot of the subgroup analyses for CSFD reducing mortality by drainage methods Secondary outcomes Twelve studies examined the correlation between hydrocephalus and CSFD in 2383 patients (1368 patients with CSFD and 1015 patients without CSFD). The results of the meta-analysis revealed that drainage did not reduce the incidence of hydrocephalus (OR: 0.84, 95% CI: 0.50–1.42, P = 0.51) (Fig. 4A). Owing to the high degree of heterogeneity (P = 0.000, I2 = 75.4%), meta-regression analyses were performed. Meta-regression did not reveal a source of heterogeneity (Supplementary Table S4B). The subgroup analyses by study type (RCT: OR: 0.71, 95% CI: 0.30–1.69, P = 0.44; cohort study: OR: 0.91, 95% CI: 0.46–1.80, P = 0.79) and drainage method (LD: OR: 0.72, 95% CI: 0.42–1.25, P = 0.24; EVD: OR: 2.10, 95% CI: 0.96–4.59, P = 0.06) did not show differences, both indicating that drainage did not reduce the incidence of hydrocephalus (Fig. 4B, C). Forest plots of CSFD for hydrocephalus. A Forest plot of CSFD reducing hydrocephalus. B Forest plot of the subgroup analyses for CSFD reducing hydrocephalus by study type. C Forest plot of the subgroup analyses for CSFD reducing hydrocephalus by drainage methods Twelve studies reported the incidence of CVS after aSAH in 2280 patients, 1346 in the experimental group and 934 in the control group. Meta-analysis revealed that drainage reduced CVS after aSAH (OR: 0.52, 95% CI: 0.37–0.73, P < 0.01) (Fig. 5A). Meta-regression analyses were performed because of the high degree of heterogeneity (P = 0.010; I2 = 55.5%), and no source of heterogeneity was found (Supplementary Table S4C). In the subgroup analysis by study type, the results in both the cohort study subgroup (OR: 0.54, 95% CI: 0.36–0.80, P < 0.01) and the RCT subgroup (OR: 0.43, 95% CI: 0.19–1.00, P = 0.05) confirmed that drainage prevented CVS (Fig. 5B). In the subgroup analysis by drainage methods, the results in both the LD subgroup (OR: 0.51, 95% CI: 0.32–0.81, P < 0.01) and the EVD subgroup (OR: 0.55, 95% CI: 0.33–0.91, P = 0.02) indicated that drainage prevented CVS (Fig. 5C). Forest plots of CSFD for CVS. A Forest plot of CSFD reducing CVS. B Forest plot of the subgroup analyses for CSFD reducing CVS by study type. C Forest plot of the subgroup analyses for CSFD reducing CVS by drainage methods A total of 6 studies reported the occurrence of DCI in 842 patients, 423 of whom received drainage and 419 of whom did not receive drainage. According to the meta-analysis, drainage reduced the incidence of DCI in patients after bleeding (OR: 0.57, 95% CI: 0.40–0.81, P < 0.01) (Fig. 6A). Meta-regression analysis was not performed because of low heterogeneity (P = 0.612, I2 = 0.0%). Subgroup analysis by study type revealed that drainage prevented DCI in both the RCT subgroup (OR: 0.49, 95% CI: 0.26–0.90, P = 0.02) and the cohort study subgroup (OR: 0.62, 95% CI: 0.40–0.95, P = 0.03) (Fig. 6B). Subgroup analysis by drainage method revealed that LD reduced the incidence of DCI (OR: 0.58, 95% CI: 0.40–0.84, P < 0.01) and that EVD did not prevent DCI (OR: 0.52, 95% CI: 0.18–1.49, P = 0.22) (Fig. 6C). Forest plots of CSFD for DCI. A Forest plot of CSFD reducing DCI. B Forest plot of the subgroup analyses for CSFD reducing DCI by study type. C Forest plot of the subgroup analyses for CSFD reducing DCI by drainage methods Eight studies reported postoperative intracranial infections in 1511 patients, 913 of whom received postoperative drainage and 598 of whom did not receive drainage. No heterogeneity was detected in the meta-analysis results (P = 0.570, I2 = 0.0%). Meta-analysis revealed that drainage increased the incidence of intracranial infections (OR: 2.31, 95% CI: 1.24–4.29, P < 0.01) (Fig. 7A). According to the subgroup analysis by study type, drainage increased the rate of intracranial infections in cohort studies (OR: 2.54; 95% CI: 1.13–5.73; P = 0.03) but not RCTs (OR: 1.97, 95% CI: 0.76–5.16, P = 0.17) (Fig. 7B). In the subgroup analysis by drainage method, drainage increased the rate of intracranial infection in the LD subgroup (OR: 2.49, 95% CI: 1.17–5.32, P = 0.02) but not the EVD subgroup (OR: 1.93, 95% CI: 0.66–5.69, P = 0.23) (Fig. 7C). Forest plots of CSFD for intracranial infection. A Forest plot of CSFD increasing intracranial infection. B Forest plot of the subgroup analyses for CSFD increasing intracranial infection by study type. C Forest plot of the subgroup analyses for CSFD increasing intracranial infection by drainage methods Bleeding events Five studies recorded bleeding events during drainage in 1001 patients, 567 who received postoperative drainage and 434 who did not. The results of the meta-analysis were not heterogeneous (P = 0.263, I2 = 23.7%) and revealed that drainage did not increase the incidence of bleeding events (OR: 1.04, 95% CI: 0.52–2.08, P > 0.05) (Fig. 8A). The subgroup analysis by drainage method revealed that the incidence of bleeding was not increased in either the LD subgroup (OR: 0.95, 95% CI: 0.48–1.90, P > 0.05) or the EVD subgroup (OR: 5.63, 95% CI: 0.26–120.28, P > 0.05) (Fig. 8B). Forest plots of CSFD for bleeding events. A Shows the overall effect of CSFD on bleeding events. B Forest plot of the subgroup analyses for CSFD on bleeding events by drainage methods Comparison of LD and EVD A total of 700 patients from 4 studies were included in the meta-analysis, 346 with EVD and 354 with LD. Patients who received LD had a better prognosis than those who received EVD (OR: 3.16, 95% CI: 1.37–7.33, P < 0.01) (Fig. 9A). However, meta-analysis revealed that the different drainage methods did not affect the occurrence of hydrocephalus (OR: 0.78, 95% CI: 0.37–1.65, P > 0.05), CVS (OR: 0.64, 95% CI: 0.17–2.45, P > 0.05) or cerebral infarction (OR: 0.47, 95% CI: 0.16–1.40, P > 0.05) (Fig. 9B, C, D). There were insufficient data to compare the differences between LD and EVD in terms of the incidence of DCI, intracranial infection and mortality. Forest plots comparing LD and EVD for different outcomes. A Favorable prognosis. B Cerebral vasospasm. C Hydrocephalus. D Cerebral infarction Comparison of High-grade and Low-grade This meta-analysis included 7 studies, comprising a total of 1,412 patients, with 253 in the low-grade subgroup and 1,159 in the high-grade subgroup. The meta-analysis results for the high-grade subgroup demonstrated that drainage not only improved prognosis (OR: 2.54, 95% CI: 1.12–5.79, P < 0.05) but also reduced the incidence of complications such as hydrocephalus (OR: 0.39, 95% CI: 0.15–0.98, P < 0.05), cerebral vasospasm (OR: 0.43, 95% CI: 0.30–0.61, P < 0.05) and DCI (OR: 0.42, 95% CI: 0.24–0.72, P < 0.05) (Supplementary Fig. S1A, B, C, D). In contrast, the meta-analysis of the low-grade subgroup indicated that drainage had no significant effect on prognosis or the occurrence of complications. Publication bias and sensitivity analysis To provide more reliable results, we performed a publication bias test for all the outcomes. With respect to the primary outcomes, there was no evidence of publication bias in terms of a favorable prognosis (Egger regression test, P = 0.09) or mortality (Egger regression test, P = 0.39) according to visual funnel plot inspection. Similarly, no publication bias was detected for the secondary outcomes of hydrocephalus (Egger regression test, P = 0.31), CVS (Egger regression test, P = 0.17), DCI (Egger regression test, P = 0.27), or intracranial infection (Egger regression test, P = 0.48) (Supplementary Fig. S2). Sensitivity analysis revealed that among the primary outcomes, the results for a favorable prognosis and mortality were robust. Among the secondary outcomes, the results for hydrocephalus, CVS, DCI, and intracranial infections were also robust (Supplementary Fig. S3). Discussion In this present study, we included a total of 3442 patients from 20 articles up to 1 July 2025. Overall, the results suggest that CSFD is associated with lower mortality, a lower incidence of CVS and DCI and better clinical outcomes in patients with aSAH. In addition, the results indicate that CSFD has no significant effect on the occurrence of hydrocephalus and bleeding events, but it may be associated with a higher incidence of intracranial infections. However, the effects of CSFD on the outcomes of aSAH cannot be conclusively determined due to the large differences in the results of different drainage methods and study methods, as shown by subgroup analyses. In view of the large differences in methods and outcomes between studies, several meta-analyses have been performed to analyze the effectiveness of CSFD in patients with aSAH [29–31]. Qian’s [29] research revealed that LD reduced complications such as cerebral vasospasm and hydrocephalus in patients; however, the study was hampered by the inclusion of old literature and low-quality studies. Recent studies [31] have investigated the efficacy of LD following aSAH, but there is a lack of strong evidence because of the inconsistency in the types of studies included and the small number of studies included. Prior studies have not focused entirely on the prognosis of patients or outcomes with a significant degree of heterogeneity. A study by Lee, K. S. [30]. focused on the effects of lumbar drainage on the outcomes of aneurysmal subarachnoid hemorrhage, whereas our study focused on the relationship between cerebrospinal fluid drainage and outcomes such as prognosis, mortality and complications, in terms of the different drainage styles as well as the type of study. In contrast to our results, those reported by Lee [30] revealed no association between the use of lumbar drainage and patient outcomes at 1 month, 3 months, or 6 months postoperatively, and our search included more up-to-date databases. This updated meta-analysis included more recently published literatures and modified the analysis methods. When the results were not robust, we attempted to determine the cause through subgroup analysis, meta-regression, or exploration of the deficiencies of the article itself to provide more comprehensive and reliable evidence. Considering the influence of different drainage methods and research methods on the results, we conducted subgroup analyses by drainage method and study type. Therefore, our results provide a more comprehensive evaluation of the safety and efficacy of CSFD in patients with aSAH, and our results have potential reference significance for further research on the mechanism of CSFD and the exploration of the best drainage method. Owing to the critical role of hemoglobin and its breakdown products in secondary injury, the removal of blood clots and bloody cerebrospinal fluid plays an invaluable role in the treatment of patients with aSAH. In addition, it is generally believed that the occurrence of hydrocephalus after aSAH is closely related to the volume of hemorrhage; thus, the removal of blood components may also be helpful in preventing the occurrence of secondary hydrocephalus after SAH [32]. Although neurosurgical clipping can remove blood clots more directly, it has not shown an advantage over endovascular coiling for improving prognosis and preventing hydrocephalus [33]. Moreover, with the increasing proportion of interventional surgeries for aSAH treatment, CSFD has been increasingly applied in aSAH management. In theory, drawing bloody cerebrospinal fluid out of the body improves CSF circulation, and gravity and CSF circulation can help flush residual blood clots from the brain and drain inflammatory factors and vasospastic substances, thereby promoting patient recovery. Another factor that was not considered was the impact of the CSFD on the control of intracranial pressure. CSFD may also bring benefits to patients by assisting in reducing intracranial pressure during the perioperative period. However, due to the lack of direct evidence, this conjecture still needs to be verified. Moreover, the potential damage and complications resulting from the implantation of the drainage device also need to be carefully evaluated. The effects of CSFD on aSAH patients were first reported by Yamamoto I. et al. in 1989 [12]. The authors placed drainage tubes to release cerebrospinal fluid during early surgical clipping and reported that CSFD improved cerebral vasospasm and clinical outcomes in high-grade patients. Therefore, they suggested that CSFD should be suitable for patients with high-grade aSAH and suggested that drainage tubes should be removed as early as possible according to the levels of carbonate and lactic acid in the cerebrospinal fluid. However, in this case series, CSFD significantly increased the incidence of shunt-dependent hydrocephalus. Subsequent retrospective analyses by Klimo P. et al. and Kwon, O. Y. et al. suggested that continuous lumbar drainage may be better than EVD for alleviating cerebral vasospasm and improving prognosis in patients with aSAH [8, 13]. In addition, a study by Otawara Y. et al. in patients with low-grade aSAH revealed that CSFD was not helpful for mild aSAH, which is consistent with the suggestion by Yamamoto I. et al. [12, 23]. Given that the above studies were retrospective studies with small sample sizes, the evidence level of the results was very low. In 2012, Al-Tamimi et al. conducted a prospective randomized controlled trial to verify the effect of LD on patients with aSAH [11]. Their findings revealed that while LD reduced the incidence of DCI and improved early clinical outcomes, it failed to improve outcomes at 6 months. This may be related to the fact that they included mainly patients with aSAH of a lower clinical grade (WFNS grades 1 to 3). Since then, numerous RCTs including patients with medium- to high-grade aSAH have revealed that EVD and LD were beneficial for the clinical prognosis of aSAH patients and that the mechanism was mostly related to the alleviation of ischemic complications [9, 14, 17, 20]. In a multicenter RCT published in 2023, compared with standard care, prophylactic LD did not significantly reduce the incidence of cerebral vasospasm after aSAH, but it reduced the incidence of cerebral infarction at discharge and improved functional outcomes at 6 months. The incidence of meningitis, death, and VP-dependent hydrocephalus did not differ between the two groups. Data on the length of stay and medical costs, as well as other complications such as bleeding and low cranial pressure, were not reported [25]. In terms of primary outcomes, meta-analysis revealed that CSFD was associated with better clinical outcomes and lower mortality, but the results of the subgroup analyses varied. The results of cohort studies revealed significantly higher rates of a good prognosis and lower mortality rates in patients who received CSFD than in the controls, whereas the results of RCTs revealed no difference in either functional outcome or mortality. Since no meta-regression analysis was performed, after analyzing the literature, we found that the RCT reported by Al-Tamimi [11] included only patients with WFNS grades I-III. Given that few RCTs are available, the reason for the lack of difference may be the ceiling effect caused by this study. The different original studies did not distinguish between high and low WFNS grades in the included patients; thus, we were unable to perform a subgroup analysis of the results in terms of high and low WFNS grades. Nevertheless, we extracted as much patient data as possible based on the modified Fisher grading system and conducted a subgroup analysis. The results of this analysis suggest that drainage may confer greater benefits for high-grade patients. Due to the limited data available for low-grade patients, the effect of CSFD in this subgroup remains inconclusive. Therefore, more large samples and reasonably designed RCTs are urgently needed. CVS is among the most common causes of neurological deterioration and death in patients, but the mechanism underlying its development is not clear. Previous studies [34–37] have identified oxygen-free radicals, vascular endothelial growth factor, endothelin, and protein kinase C as factors associated with the development of vasospasm. Hence, removing these risk factors in a timely manner may be an effective approach for reducing the development of CVS. Since Fisher proved the relationship between cerebral vasospasm and subarachnoid hemorrhage [38], researchers have attempted to reduce DCI by removing subarachnoid hematomas, and extracorporeal CSFD has been proposed as an effective method for preventing DCI. The findings of the prospective randomized controlled trial reported by Al-Tamimi suggested that CSFD reduces the incidence of DCI. Additionally, Al-Tamimi study had the largest sample size and described more detailed diagnostic standards for DCI, which may reduce assessment bias [11]. Kasuya H. [39] also reported that patients receiving CSFD have a lower risk of CVS than those not receiving drainage. Klimo [13] reported that compared with EVD, LD provides better results, a conclusion that was also confirmed in our study. Notably, the current study did not assess the volume or duration of drainage in detail. Consequently, there is no evidence linking the volume or duration of cerebrospinal fluid drainage to cerebral vasospasm. Future studies should focus on these points and explore the relationships between cerebrospinal fluid drainage and cerebral vasospasm more closely. Our results also confirm the previous speculation that cerebrospinal fluid drainage significantly reduces the probability of DCI after aneurysmal subarachnoid hemorrhage. Hydrocephalus is among the common complications of aSAH, and the inflammation and fibrosis caused by blood components and metabolites in the subarachnoid space are believed to be closely related to hydrocephalus. Sajanti [40] reported that the levels of both carboxy-terminal propeptide type I collagen-containing and chloride-containing propeptide type III procollagen were greater in the cerebrospinal fluid of patients with hydrocephalus than in those without hydrocephalus. Studies have shown that the inflammatory response induced by platelets and glial cells entering the subarachnoid space can release transforming growth factor-β1, which increases protein aggregation through a series of signaling pathways and causes thickening of subarachnoid adhesions, resulting in occlusion of the subarachnoid villi, vascular spaces, and perineural spaces, obstructing CSF circulation and inducing hydrocephalus [41, 42]. Researchers believe that if the bloody cerebrospinal fluid component is effectively removed from the subarachnoid system in a timely and efficient manner, the obstruction to cerebrospinal fluid circulation can be effectively removed, and the incidence of hydrocephalus can be reduced [12]. However, this updated meta-analysis still revealed that compared with no drainage, drainage did not affect the occurrence of hydrocephalus after hemorrhage in patients. Moreover, a recent report suggested that EVD and a large drainage volume are independent risk factors for shunt-dependent hydrocephalus after aSAH [43]. Therefore, the effect of CSFD on hydrocephalus may need to be reconsidered. Another factor to consider is that excessive CSFD may lead to increased adhesion of the subarachnoid space and arachnoid particles. Since the subgroup analysis of different CSFD methods showed that the effects of LD and EVD on the primary outcome were not consistent, we extracted four studies that conducted a head-to-head comparison of EVD and LD, and analyzed the impact of different drainage methods on functional outcomes and complications. The results of the further meta-analysis still showed that the functional outcomes of the LD group were significantly better than those of the EVD group. However, there was no significant difference in the incidence of hydrocephalus and CVS between the LD group and the EVD group. Moreover, due to the lack of sufficient data, it is difficult to directly compare the effects of LD and EVD on the occurrence of complications such as DCI, II, and bleeding events. Due to the methodological shortcomings of the included retrospective cohort studies and the lack of large-sample RCTs, it is still far from conclusive whether LD is superior to EVD. However, based on the published papers, it seems that the researchers are more inclined to apply LD (10 of 16 papers) rather than EVD (6 of 16papers). Whether it is about choosing a more appropriate drainage device or clarifying the mechanism of CSFD, well-designed multi-center RCTs are urgently needed. This updated systematic review and meta-analysis comprehensively and thoroughly analyzed the safety and efficacy of CSFD in aSAH and compared different CSFD methods. However, this study still has many limitations. First, we were not able to search all the databases or consult all the gray literature, so the information collected may be incomplete, which may have had some influence on the results. Second, some studies did not record detailed follow-up time points for prognosis. Bias may have resulted from different follow-up times among studies. Third, after assessing the safety of cerebrospinal fluid drainage, we found that drainage increases the risk of intracranial infection but has no significant effect on bleeding events, and there are insufficient research data on the assessment of catastrophic complications such as brain herniation [44]. In addition, there are no strict criteria for drainage time or drainage volume across studies, and different treatment strategies may explain the significant heterogeneity of the results and variable outcomes. Furthermore, most of the included studies were retrospective, which may have contributed to the inconsistent results in the study type subgroup analyses. More randomized controlled studies are needed to confirm the current findings. Future studies need to pay further attention to the effects of different drainage times, drainage volumes, and drainage methods on the prognosis and complications of patients. More authoritative and uniform criteria are needed for the prognostic follow-up of patients and the diagnosis of complications. Conclusion This study systematically reviewed retrospective cohort studies and randomized controlled trials of CSFD application in patients with aSAH and conducted a meta-analysis. The results showed that CSFD was associated with better functional prognosis and lower mortality, CVS and DCI incidence in aSAH patients. Furthermore, this meta-analysis also revealed that CSFD not only failed to prevent hydrocephalus but also increased the risk of intracranial infection. Due to the methodological limitations in the included studies and the high heterogeneity, well-designed prospective RCTs are needed to clarify the role and mechanism of CSFD in aSAH and to guide the development of more effective CSFD strategies. Supplementary Information Below is the link to the electronic supplementary material. Supplementary file1 (TIF 18885 KB) Fig. S1 Forest plots of the subgroup analyses for CSFD on outcomes by Fisher grade. A. Favorable prognosis. B. Hydrocephalus. C. Cerebral vasospasm. D. Delayed cerebral ischemia Supplementary file2 (TIF 11191 KB) Fig. S2 Primary and Secondary Outcome Funnel Plot Supplementary file3 (TIF 75449 KB) Fig. S3 Sensitivity Analysis of Primary and Secondary Outcomes Supplementary file4 (DOCX 19 KB) Supplementary file5 (DOCX 17 KB) Supplementary file6 (DOCX 21 KB) Supplementary file7 (DOCX 19 KB) Author contributions All authors contributed to the study conception and design. Data collection and analysis were performed by Xinlong Chen, Long Zhao and Xiaoping Tang. The first draft of the manuscript was written by Xinlong Chen and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript. Data availability Data relevant to this study can be obtained from the corresponding author upon reasonable request. Declarations Conflicts of interest None. Footnotes Xinlong Chen, Peijun Zhao and Xingyuan Huang contributed equally to this work. Contributor Information Xiaoping Tang, Email: nsmc_txping1971@163.com. Long Zhao, Email: cbyzhaolong@163.com. References Associated Data Supplementary Materials Supplementary file1 (TIF 18885 KB) Fig. S1 Forest plots of the subgroup analyses for CSFD on outcomes by Fisher grade. A. Favorable prognosis. B. Hydrocephalus. C. Cerebral vasospasm. D. Delayed cerebral ischemia Supplementary file2 (TIF 11191 KB) Fig. S2 Primary and Secondary Outcome Funnel Plot Supplementary file3 (TIF 75449 KB) Fig. S3 Sensitivity Analysis of Primary and Secondary Outcomes Supplementary file4 (DOCX 19 KB) Supplementary file5 (DOCX 17 KB) Supplementary file6 (DOCX 21 KB) Supplementary file7 (DOCX 19 KB) Data Availability Statement Data relevant to this study can be obtained from the corresponding author upon reasonable request.